There are currently three approved vaccines against the H5N1 avian influenza virus. However, they present challenges for large-scale virus cultivation in case of an outbreak and rapid update of vaccine strains to keep pace with the virus’s evolution. Messenger RNA (mRNA) vaccine platforms may offer a promising alternative to traditional vaccine methods to face H5N1 threats.